Comparative Study
. 2005 Jan 18;45(2):327-8; author reply 328.
doi: 10.1016/j.jacc.2004.10.026.
Advantage of percutaneous coronary intervention over medical therapy in angina relief and the placebo effect
- PMID: 15653043
- DOI: 10.1016/j.jacc.2004.10.026
Item in Clipboard
Comparative Study
Advantage of percutaneous coronary intervention over medical therapy in angina relief and the placebo effect
J Am Coll Cardiol.
.
Free article
No abstract available
Comment on
-
The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.J Am Coll Cardiol. 2004 May 19;43(10):1743-51. doi: 10.1016/j.jacc.2003.08.065. J Am Coll Cardiol. 2004. PMID: 15145093 Clinical Trial.
Similar articles
-
Current treatment status of stable angina: medical treatment versus percutaneous coronary intervention versus coronary artery by-pass grafting.J Indian Med Assoc. 2009 Oct;107(10):685-6, 691-4. J Indian Med Assoc. 2009. PMID: 20469742 Review. No abstract available.
-
Re: One year perspective on COURAGE.Catheter Cardiovasc Interv. 2009 Feb 15;73(3):428. doi: 10.1002/ccd.21848. Catheter Cardiovasc Interv. 2009. PMID: 19133682 No abstract available.
-
Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.Rev Cardiovasc Med. 2007 Fall;8(4):234-9. Rev Cardiovasc Med. 2007. PMID: 18192947 Review. No abstract available.
-
Counterpoint: Mechanical treatment of atherosclerosis is not a cure.Prev Cardiol. 2009 Fall;12(4):171-2. doi: 10.1111/j.1751-7141.2009.00046.x. Prev Cardiol. 2009. PMID: 19751479 No abstract available.
-
Does percutaneous coronary intervention reduce mortality in patients with stable chronic angina: are we talking about apples and oranges?Circ Cardiovasc Qual Outcomes. 2009 Mar;2(2):123-6. doi: 10.1161/CIRCOUTCOMES.108.834853. Circ Cardiovasc Qual Outcomes. 2009. PMID: 20031824 No abstract available.
Cited by
-
The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: A meta-analysis.Clin Cardiol. 2024 Feb;47(2):e24238. doi: 10.1002/clc.24238. Clin Cardiol. 2024. PMID: 38400562 Free PMC article. Review.
-
The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis.Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S406-S418. doi: 10.1016/j.ihj.2018.01.032. Epub 2018 Jan 31. Indian Heart J. 2018. PMID: 30595300 Free PMC article. Review.
-
Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach.Diagnostics (Basel). 2023 Feb 13;13(4):709. doi: 10.3390/diagnostics13040709. Diagnostics (Basel). 2023. PMID: 36832197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
